Rowlatt Robotics official logo showing the words Rowlatt and Robotics stacked vertically.

Privacy Policy

ROWLATT ROBOTICS - B2B PRIVACY POLICY
Effective Date: May 22, 2026
Last Updated: May 22, 2026
1. Introduction and Scope
Rowlatt Robotics ("Rowlatt Robotics," "the Company," or "the Enterprise") engineers advanced predictive artificial intelligence built upon a unified cognitive architecture. The Company provides B2B predictive molecular interaction modeling for the biopharmaceutical industry and ultra-efficient control frameworks for decentralized edge robotics.
Rowlatt Robotics is unequivocally committed to the rigorous protection of privacy and data security. This Privacy Policy details the frameworks governing the collection, utilization, storage, and disclosure of personal information in strict accordance with the Privacy Act 1988 (Cth), the Australian Privacy Principles (APPs), and the Privacy and Other Legislation Amendment Act 2024 (Cth). By engaging with the Enterprise, participating in the research network, or deploying the computational platforms, the User and Client acknowledge the data processing practices established within this Policy.
2. Legal Definitions
* Personal Information: Information or an opinion concerning an identified individual, or an individual who is reasonably identifiable, regardless of whether the information or opinion is factual or recorded in a material form.
* Sensitive Information: A legally protected sub-category of personal information requiring elevated safeguards. Within the operational scope of Rowlatt Robotics, this explicitly encompasses "health information" and "genetic information that is or could be predictive of the health of the individual" (biological, molecular, and genomic datasets).* Automated Decision-Making (ADM): The utilization of the Company's computational frameworks, artificial intelligence algorithms, and probabilistic reasoning models to either fully automate or substantially and directly assist human decision-making operations.* Data Controller: The enterprise Client determining the purpose and parameters of data processing.* Data Processor: Rowlatt Robotics, when executing predictive modeling exclusively upon the instructions of the Client.3. Categorization of Collected Information
Operating exclusively within the B2B enterprise sector, Rowlatt Robotics segments data collection into two distinct operational streams:
A. Business & Operational Information (Controller Capacity)
The Company collects personal information fundamentally necessary for the administration of commercial relationships, including:
* Professional contact nomenclature (names, corporate titles, business email addresses, professional telephone coordinates) of researchers, industry peers, and enterprise partners.
* Commercial correspondence concerning partnership negotiations, technical demonstrations, and contractual support.
* Digital analytics, IP addresses, and session telemetry acquired through authorized cookies to optimize the architecture of the primary digital platform.
B. Client & Research Data (Processor Capacity)
When enterprise clients deploy the cognitive engine for drug discovery or cyber-physical robotics, they may transmit datasets to the Company infrastructure. Subject to the specific deployment, this may include:
* De-identified, pseudonymized, or synthetic biological, molecular, and genomic sequencing data.
* Sensor telemetry and environmental interaction mapping from physical edge robotics, which may incidentally capture human spatial positioning or thermal signatures.
* Data Minimization Doctrine: Rowlatt Robotics operates under a strict principle of data minimization. Clients are contractually obligated to execute legal anonymization protocols upon all health and genomic data prior to system ingestion, unless a legally compliant Data Processing Agreement (DPA) explicitly authorizing the transfer of identifiable sensitive information has been executed.4. Methodologies of Collection
Personal information is collected exclusively through lawful, fair, and transparent methodologies, including:
* Direct Acquisition: Initiated when personnel contact the Company, register for network communications, or formalize corporate partnership agreements.* Third-Party Transfer: Initiated when biopharmaceutical clients or academic research institutions securely transmit analytical datasets to the computational engine via end-to-end encrypted Application Programming Interfaces (APIs).* Decentralized Telemetry: As autonomous decision-making algorithms operate within edge environments, real-time spatial telemetry necessary for systemic adaptation is continuously acquired.* Absolute Prohibition on Public Scraping: Rowlatt Robotics explicitly does not deploy automated extraction tools (web scraping) to harvest publicly identifiable personal, health, or genomic information from the open internet for the purpose of training the core AI engine. Training datasets are strictly restricted to highly curated, legally licensed, or purely synthetic data structures to ensure unassailable provenance.5. Purpose of Collection, Use, and Disclosure
The Enterprise utilizes personal and sensitive information strictly for the primary commercial purposes for which it was acquired, or a proximate secondary purpose reasonably anticipated by the Data Subject. These authorized purposes include:
* Enterprise Service Delivery: To integrate the multi-system adaptation architecture into Client pipelines, accelerating drug discovery protocols or executing physical control frameworks.* Core Engine Research & Development: To architect, stress-test, and mathematically refine the probabilistic reasoning underlying the commercial models. The Company deploys irreversible de-identification protocols prior to utilizing any aggregated Client telemetry for foundational model enhancement.* Algorithmic Accuracy and Assurance (APP 10): To subject all operational datasets to rigorous qualitative analysis, ensuring the predictive models do not output inaccurate, discriminatory, or hallucinated anomalies that could compromise scientific research integrity.* Statutory Compliance: To satisfy regulatory audits, mitigate fraudulent activities, and maintain adherence to the jurisdictional requirements of Australian law.Rowlatt Robotics absolutely prohibits the monetization or sale of personal information to third-party data brokers. Information may be disclosed to highly vetted, ISO-27001 certified cloud infrastructure providers strictly for the technical hosting of the computational frameworks.6. Substantially Automated Decision-Making (ADM) Disclosures
Statutory Compliance Notice: This provision is enacted in proactive satisfaction of the transparency obligations mandated by APPs 1.7, 1.8, and 1.9, effective December 10, 2026.
Rowlatt Robotics engineers advanced "computer programs" (incorporating predictive artificial intelligence and machine learning algorithms) that process multi-dimensional data inputs to generate probabilistic insights. Operating as a B2B technology vendor, the AI engine deployed by the Company may substantially and directly assist human personnel within Client organizations to formulate decisions that could reasonably be expected to significantly affect the rights or interests of individuals (e.g., the progression of patient health pathways within clinical trials).
A. Kinds of Data Inputs Utilized in ADM:
The algorithmic models process complex data inputs, encompassing historical molecular interaction matrices, probabilistic genomic sequence structures (where legally provided by the Client), and real-time spatial telemetry acquired from edge robotic sensors.
B. Human-in-the-Loop Assisted Decision-Making:
The biopharmaceutical predictive models engineered by Rowlatt Robotics are not fully autonomous diagnostic or determinative clinical tools. The architecture is designed as a singular cognitive engine providing advanced candidate filtering and predictive molecular mapping to substantially and directly support the evaluative capabilities of human researchers. The ultimate determinative decision regarding the viability of therapeutic pathways and clinical drug discovery rests entirely and irrevocably with the human scientists and medical professionals at the respective partner organizations.
C. Fully Automated Edge Operations:
Within decentralized cyber-physical environments, the edge robotics control frameworks may execute fully autonomous, real-time spatial navigation and mechanical decisions entirely devoid of human intervention. These automated decisions are strictly localized to mechanical telemetry and physical environment navigation, engineered with fail-safes to maximize operational efficiency and physical safety.
7. Cross-Border Disclosures (APP 8)
Operating a highly scalable, enterprise-level architecture necessitates the utilization of global cloud infrastructure. Consequently, the Company may transmit personal information to servers geographically located outside the sovereign borders of Australia (e.g., the United States or the European Union). Rowlatt Robotics shall only initiate international data transfers if an objective determination is made that the receiving entity is subject to a legal regime substantially similar to the APPs (such as the GDPR), or if robust, legally binding contractual safeguards (such as Standard Contractual Clauses) have been executed to guarantee data security.
8. Data Security, Integrity, and Retention (APP 11)
The Enterprise deploys uncompromising, military-grade technical and organizational measures to insulate personal information from misuse, interference, loss, unauthorized access, modification, or disclosure. The architectural security framework mandates:
* Asymmetric end-to-end encryption of all datasets, both during transit and at rest.
* Implementation of strict Role-Based Access Controls (RBAC) and mandatory Multi-Factor Authentication (MFA) across all engineering and administrative environments.
* A secure-by-design deployment topology ensuring absolute physical and digital isolation between sensitive biological datasets and cyber-physical telemetry.
* Routine cryptographic hashing and proactive de-identification of all research training environments.
Rowlatt Robotics retains personal information only for the duration reasonably necessary to execute the operational objectives defined within this Policy, or as strictly mandated by statutory law. Upon expiration of the required retention period, the Company initiates protocols to permanently and irreversibly destroy or de-identify the data.9. Subject Access, Correction, and Legal Rights
Individuals possess the statutory right to request access to the personal information maintained by the Company, and to demand formal corrections if the data is deemed inaccurate, out-of-date, incomplete, irrelevant, or misleading.
To exercise these statutory rights, or to initiate an opt-out protocol regarding B2B marketing communications, communications must be directed to the designated Privacy Officer. Rowlatt Robotics shall formulate a response within a reasonable timeframe (typically 30 days) and shall not levy any financial charges for the processing of such requests.
10. Formal Contact Information
For inquiries, legal concerns, or formal complaints regarding this Privacy Policy or the enterprise data processing frameworks, please contact the legal and compliance administration:
Email: [email protected]If a resolution regarding a privacy complaint is deemed unsatisfactory, the individual retains the inalienable right to escalate the matter to the Office of the Australian Information Commissioner (OAIC) via their official digital portal.